Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Abbott Laboratories - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABT
New York
2836
www.abbott.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Abbott Laboratories
RFK Jr.’s Next Overhaul: America’s Baby Formula Guidelines
- Feb 16th, 2026 7:00 pm
Canada Point of Care Molecular Diagnostics Market Research Report 2025-2030: Digital Health Platforms, Multiplex PCR Adoption, and Pharmacogenomics Programs Bolster Growth
- Feb 16th, 2026 3:46 am
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down
- Feb 15th, 2026 9:41 pm
Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects?
- Feb 15th, 2026 4:00 am
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio
- Feb 13th, 2026 4:01 pm
SNY Stock Falls After Board Suddenly Makes Leadership Change
- Feb 13th, 2026 10:55 am
Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer
- Feb 13th, 2026 4:15 am
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky
- Feb 12th, 2026 9:41 pm
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?
- Feb 12th, 2026 11:04 am
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever
- Feb 12th, 2026 4:35 am
1 Reason I'm Never Selling AbbVie Stock
- Feb 12th, 2026 3:04 am
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT)
- Feb 11th, 2026 4:01 am
4 takeaways from the 2026 AF Symposium
- Feb 10th, 2026 3:53 am
3 Market-Beating Stocks to Research Further
- Feb 8th, 2026 9:41 pm
Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating
- Feb 8th, 2026 2:27 am
Insider Stock Buying Reaches US$3.10m On Abbott Laboratories
- Feb 7th, 2026 4:00 am
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
- Feb 6th, 2026 7:00 am
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
- Feb 6th, 2026 6:00 am
Top Picks 2026- AbbVie Inc. ABBV
- Feb 5th, 2026 10:01 pm
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Feb 5th, 2026 5:00 am
Scroll